Authentication of Schisandra chinensis and Schisandra sphenanthera in Chinese patent medicines
- 1 November 2016
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 131, 263-271
- https://doi.org/10.1016/j.jpba.2016.08.040
Abstract
No abstract availableKeywords
Funding Information
- Chinese Pharmacopoeia Commission
This publication has 22 references indexed in Scilit:
- Characterization and classification of seven Citrus herbs by liquid chromatography–quadrupole time-of-flight mass spectrometry and genetic algorithm optimized support vector machinesJournal of Chromatography A, 2014
- Antioxidant and hepatoprotective effects of Schisandra chinensis pollen extract on CCl4-induced acute liver damage in miceFood and Chemical Toxicology, 2013
- Unbiased metabolite profiling by liquid chromatography–quadrupole time-of-flight mass spectrometry and multivariate data analysis for herbal authentication: Classification of seven Lonicera species flower budsJournal of Chromatography A, 2012
- Advanced development in analysis of phytochemicals from medicine and food dual purposes plants used in ChinaJournal of Chromatography A, 2011
- Isolation and analysis of ginseng: advances and challengesNatural Product Reports, 2011
- Analysis of Schisandra chinensis and Schisandra sphenantheraJournal of Chromatography A, 2008
- Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicineJournal of Ethnopharmacology, 2008
- Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation modelsTrAC Trends in Analytical Chemistry, 2007
- Improvement of Phase I Drug Metabolism with Schisandra chinensis Against CCl4 Hepatotoxicity in a Rat ModelPlanta Medica, 2000
- Effect of a Lignan-Enriched Fructus Schisandrae Extract on Hepatic Glutathione Status in Rats: Protection against Carbon Tetrachloride ToxicityPlanta Medica, 1995